Codeine: Clinical Trials

5 trials of Codeine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting. 5 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Active not recruiting 1
Phase 12Completed 2
Phase 31Completed 1

Follow Codeine: new trials by email Literature Review of Codeine trials Research Report on Codeine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet, Naproxen 500 Mg, Opioids - Opioid Use, Opioid Dependence
Phase 2Active not recruitingNorthwestern University602021-01-012024-11-27
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)2242017-01-272026-03-09
Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee
placebo, GZ389988, acetaminophen or paracetamol - Osteoarthritis
Phase 2CompletedGenzyme, a Sanofi Company1042016-07-212022-04-13
Idiopathic Intracranial Hypertension Treatment Trial
Acetazolamide, Placebo, Formal weight loss counselling program - Idiopathic Intracranial Hypertension
Phase 2 / Phase 3CompletedSt. Luke's-Roosevelt Hospital Center1652010-01-012018-12-12
Codeine in Sickle Cell Disease
Codeine (30 mg) - Sickle Cell Disease
Phase 1 / Phase 2CompletedPriCara, Unit of Ortho-McNeil, Inc.602005-03-012011-06-30

Conditions studied

Pain (2)  ·  Anemia, Sickle Cell (1)  ·  Back Injuries (1)  ·  Back Pain (1)  ·  Carcinoma in Situ (1)  ·  Chronic Pain (1)  ·  Diplopia (1)  ·  Headache (1)  ·  Obesity (1)  ·  Opioid-Related Disorders (1)  ·  Osteoarthritis (1)  ·  Papilledema (1)  ·  Papillomavirus Infections (1)  ·  Pseudotumor Cerebri (1)  ·  Tinnitus (1)

Sponsors

Genzyme, a Sanofi Company (1)  ·  National Cancer Institute (NCI) (1)  ·  Northwestern University (1)  ·  PriCara, Unit of Ortho-McNeil, Inc. (1)  ·  St. Luke's-Roosevelt Hospital Center (1)

Countries

United States (4)  ·  Canada (1)  ·  Germany (1)

Top investigators

Apkar V Apkarian, PhD (1)  ·  Michael Wall, MD (1)  ·  Scott M Norberg, D.O. (1)  ·  Stacy S. Shord, PharmD (1)

Results publications

PMID 24756302, PMID 24756514, PMID 24781936, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27694262, PMID 28130349, PMID 28492874, PMID 31351965, PMID 33558725

NIH funding

2014 (1), U10EY017281 (1), U10EY017387 (1)